Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Promising new colon-specific 5-ASA prodrug developed by U.S. and Korean scientists

Oct. 31, 2000

Safe new agents from Ajinomoto with potential in irritable bowel syndrome

Oct. 30, 2000

Pharmacokinetics, disposition and metabolism of new hepatic antiinflammatory TA-510

Oct. 30, 2000

Selective M3 receptor antagonists and their use described by Japanese scientists

Oct. 24, 2000

Prilosec receives positive recommendation for OTC status

Oct. 24, 2000

Encouraging data reported for Emitasol in diabetic gastroparesis

Oct. 23, 2000

IND for hepatitis C gene fusion therapy submitted by Human Genome Sciences

Oct. 20, 2000

IBS treatment launched in Japan by Hokuriku and Fujisawa

Oct. 19, 2000

Phase III trial reveals potency of H. pylori treatment

Oct. 19, 2000

Effects of repeated doses of YF-476 on gastric pH examined in healthy volunteers

Oct. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...